Back
Viking Therapeutics Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
VKTX
Viking Therapeutics
Last Price:
$22.21
Seasonality Move:
11.55%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Viking Therapeutics Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics has on average historically risen by 115.8% based on the past 9 years of stock performance.
-
Viking Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Viking Therapeutics Stock Undervalued?The current Viking Therapeutics [VKTX] share price is $21.52. The Score for VKTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics has on average historically risen by 115.8% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Sell
27
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics overpriced?
-
Viking Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
81.86
52-Week Low:
18.92
Prediction Charts
Market Cap:
2.4B
Price in USD:
21.52
Volume:
4.5M
Beta:
1.39
Technical Analysis
SMA50:
28.61
SMA100:
36.70
SMA200:
48.58
52-Wk Change:
-69.97%
Stock Predictions
-
Is Viking Therapeutics stock public?Yes, Viking Therapeutics is a publicly traded company.
-
What is the Viking Therapeutics stock quote today?The Viking Therapeutics stock price is 21.52 USD today.
-
How to buy Viking Therapeutics stock online?You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 29.09 | 29.28 | 29.60 | 28.20 |
| Mar-25 | 29.51 | 27.98 | 29.56 | 27.76 |
| Mar-26 | 28.00 | 26.34 | 28.19 | 25.80 |
| Mar-27 | 26.33 | 26.13 | 27.23 | 26.09 |
| Mar-28 | 25.98 | 25.65 | 26.23 | 25.21 |
| Mar-31 | 24.46 | 24.15 | 24.50 | 23.27 |
| Apr-1 | 24.15 | 23.91 | 24.54 | 23.29 |
| Apr-2 | 23.48 | 25.68 | 25.75 | 23.46 |
| Apr-3 | 24.44 | 24.22 | 25.88 | 24.07 |
| Apr-4 | 23.41 | 22.62 | 23.66 | 21.53 |
| Apr-7 | 20.79 | 21.28 | 23.00 | 20.27 |
| Apr-8 | 22.35 | 19.98 | 22.74 | 19.58 |
| Apr-9 | 19.63 | 23.10 | 23.64 | 18.92 |
| Apr-10 | 22.00 | 21.52 | 22.49 | 20.41 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.54 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.